Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hypertension, Portal × Liver Transplantation × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 3 Carcinoma, Hepatocellular 3 Colorectal Neoplasms 2 Neoplasms 1 Neoplasm Metastasis 1 Hypertension, Portal 1 Gallbladder Neoplasms 1 Fibrosis 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Bile Duct Neoplasms 1

Interventions

tremelimumab 1 durvalumab 1 Liver Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05027425 2024-11-22

Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant

University of Cincinnati

Phase 2 Active not recruiting

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hypertension, Portal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡